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Abstract
Objective:  We  compared  the  effects  of  lidocaine  and  esmolol  infusions  on  intraoperative  hemo-
dynamic  changes,  intraoperative  and  postoperative  analgesic  requirements,  and  recovery  in
laparoscopic  cholecystectomy  surgery.
Methods:  The  ﬁrst  group  (n  =  30)  received  IV  lidocaine  infusions  at  a  rate  of  1.5  mg/kg/min  and
the second  group  (n  =  30)  received  IV  esmolol  infusions  at  a  rate  of  1  mg/kg/min.  Hemodynamic
changes,  intraoperative  and  postoperative  analgesic  requirements,  and  recovery  characteristics
were evaluated.
Results:  In  the  lidocaine  group,  systolic  arterial  blood  pressures  values  were  lower  after  the
induction  of  anesthesia  and  at  20  min  following  surgical  incision  (p  <  0.05).  Awakening  time  was
shorter in  the  esmolol  group  (p  <  0.001);  Ramsay  Sedation  Scale  scores  at  10  min  after  extubation
were lower  in  the  esmolol  group  (p  <  0.05).  The  modiﬁed  Aldrete  scores  at  all  measurement  time
points during  the  recovery  period  were  relatively  lower  in  the  lidocaine  group  (p  <  0.05).  The
time to  attain  a  modiﬁed  Aldrete  score  of  ≥9  points  was  prolonged  in  the  lidocaine  group
(p <  0.01).  Postoperative  resting  and  dynamic  VAS  scores  were  higher  in  the  lidocaine  group  at
10 and  20  min  after  extubation  (p  <  0.05,  p  <  0.01,  respectively).  Analgesic  supplements  were
less frequently  required  in  the  lidocaine  group  (p  <  0.01).
Conclusion:  In  laparoscopic  cholecystectomies,  lidocaine  infusion  had  superiorities  over
esmolol infusions  regarding  the  suppression  of  responses  to  tracheal  extubation  and  postopera-
tive need  for  additional  analgesic  agents  in  the  long  run,  while  esmolol  was  more  advantageous
with respect  to  rapid  recovery  from  anesthesia,  attenuation  of  early  postoperative  pain,  and
modiﬁed  Aldrete  recovery  (MAR)  scores  and  time  to  reach  MAR  score  of  9  points.a  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  All  rights© 2014  Sociedade  Brasileir
reserved.∗ Corresponding author.
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Efeitos  das  infusões  de  lidocaína  e  esmolol  sobre  as  alterac¸ões  hemodinâmicas,
necessidade  de  analgésicos  e  recuperac¸ão  após  colecistectomia  laparoscópica
Resumo
Objetivo:  Comparamos  os  efeitos  de  infusões  de  lidocaína  e  esmolol  sobre  as  alterac¸ões  hemod-
inâmicas no  período  intraoperatório,  a  necessidade  de  analgésicos  intra-  e  pós-operatoriamente
e a  recuperac¸ão  após  colecistectomia  laparoscópica.
Métodos:  O  primeiro  grupo  (n  =  30)  recebeu  infusões  IV  de  lidocaína  a  uma  taxa  de
1,5 mg/kg/min  e  o  segundo  grupo  (n  =  30)  recebeu  infusões  IV  de  esmolol  a  uma  taxa  de  1  mg
kg/min. Alterac¸ões  hemodinâmicas,  necessidade  de  analgésicos  no  intra-  e  pós-operatório  e
características  da  recuperac¸ão  foram  avaliadas.
Resultados:  No  grupo  lidocaína,  os  valores  da  pressão  arterial  sistólica  foram  menores  após  a
induc¸ão da  anestesia  e  20  minutos  após  a  incisão  cirúrgica  (p  <  0,05).  O  tempo  até  o  despertar
foi menor  no  grupo  esmolol  (p  <  0,001),  os  escores  na  escala  de  Sedac¸ão  de  Ramsay  10  minutos
após a  extubac¸ão  foram  menores  no  grupo  esmolol  (p  <  0,05).  Os  escores  de  Aldrete  modiﬁcados
em todos  os  tempos  mensurados  durante  o  período  de  recuperac¸ão  foram  relativamente  baixos
no grupo  lidocaína  (p  <  0,05).  O  tempo  necessário  para  atingir  um  escore  de  Aldrete  ≥  9  pon-
tos foi  prolongado  no  grupo  lidocaína  (p  <  0,01).  Os  escores  Eva  em  repouso  e  em  movimento
no pós-operatório  foram  maiores  no  grupo  lidocaína  nos  minutos  10  e  20  após  a  extubac¸ão
(p <  0,05,  p  <  0,01,  respectivamente).  Analgésicos  suplementares  foram  necessários  com  menos
frequência  no  grupo  lidocaína  (p  <  0,01).
Conclusão:  Em  colecistectomia  laparoscópica,  a  infusão  de  lidocaína  foi  superior  às  infusões
de esmolol  quanto  a  suprimir  as  respostas  à  extubac¸ão  traqueal  e  necessidade  de  analgésicos
adicionais  no  pós-operatório,  enquanto  esmolol  foi  mais  vantajoso  quanto  à  rápida  recuperac¸ão
da anestesia,  à  atenuac¸ão  da  dor  no  pós-operatório  imediato  e  aos  escores  de  recuperac¸ão  de
Aldrete modiﬁcado  (RAM)  e  o  tempo  até  atingir  o  escore  RAM  de  9  pontos.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os
direitos reservados.
I
D
r
s
m
a
o
a
o
n
p
d
i
s
p
g
a
m
r
p
s
t
g
t
b
i
l
e
h
r
M
T
a
t
P
b
h
b
a
e
g
p
t
sntroduction
uring  the  perioperative  period,  as  a  hemodynamic
esponse  to  laryngoscopy,  intubation,  and  surgical  exci-
ion,  complications  including  tachycardia,  hypertension,
yocardial  ischemia,  arrhythmia,  myocardial  infarction,
nd  cerebral  hemorrhages  can  be  seen.  To  prevent  devel-
pment  of  these  unwanted  effects,  various  measures  such
s  increasing  the  depth  of  anesthesia  and  the  administration
f  topical  anesthesia,  IV  lidocaine,  vasodilators,  alfa2 ago-
ists,  beta-adrenergic  blockers,  opioids,  and  precurarizaton
rocedures  have  been  implemented.1--4
In  the  control  of  unfavorable  hemodynamic  changes
eveloped  secondary  to  intubation,  lidocaine  can  be  admin-
stered  intravenously  before  the  induction  of  anesthesia  and
everal  studies  have  demonstrated  its  preventive  effects  on
ostoperative  pain.5--7
Esmolol  is  effective  in  the  suppression  of  adrener-
ic  responses  against  laryngoscopic  procedures,  intubation,
nd  many  other  perioperative  stimulations.8,9 Further-
ore,  some  studies  have  indicated  that  beta  adrenergic
eceptor  blockers  decrease  the  need  for  anesthetics  and
ostoperative  analgesic  consumption.10--12 Even  though  pain
cores  are  lower  in  laparoscopic  colecystectomy  relative
o  conventional  open  chlecystectomy,  multimodal  anal-
esic  regimens  should  be  performed,  including  preoperative
reatment.13
p
t
sThough  many  studies  have  compared  the  effects  of
oth  drugs  on  hemodynamic  responses,  comparative  stud-
es  related  to  their  effects  on  recovery  and  analgesia  are
acking.  In  our  study,  we  have  aimed  to  compare  the
ffects  of  lidocaine  and  esmolol  infusions  on  intraoperative
emodynamic  changes,  intra-  and  postoperative  analgesic
equirements,  and  recovery.
aterials and methods
his  double-blind  study  was  performed  on  60  ASA  I-II  patients
ged  18--65  years  scheduled  for  laparoscopic  cholecystec-
omy  after  obtaining  informed  consent  from  of  the  patients.
atients  with  allergies  to  local  anesthetics  and  opioids,  mor-
id  obesity,  or  advanced  respiratory,  renal,  hematological,
epatic  or  cardiovascular  diseases;  chronic  use  of  opiate,
eta  adrenergic  receptor  antagonists,  or  alcohol;  and  drug
ddicts,  pregnant  women,  and  mentally  retarded  cases  were
xcluded  from  the  study.  For  premedication,  patients  were
iven  40  mg  famotidine  and  10  mg  diazepam  orally.  The
atients  underwent  electrocardiographic  (EKG)  examina-
ions,  pulse  oxymetric  measurements  of  peripheral  oxygen
aturation  (SpO2),  and  noninvasive  monitoring  of  arterial
ressure.  The  patients  were  randomized  into  2  groups  using
he  sealed  envelope  method.
The  ﬁrst  group  (group  L)  received  an  IV  lidocaine  infu-
ion  slowly  at  a  rate  of  1.5  mg/kg/min  for  a  total  dose  of
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Postoperative  systolic  blood  pressures  (mmHg)  did  not
differ  between  groups  in  all  measurement  periods  (p  >  0.05).
Hypotension  developed  in  one  patient  in  the  lidocaine  group,
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2  mg/kg/h  3  min  before  the  induction  of  anesthesia.  The
second  group  (group  E)  was  given  IV  esmolol  infusion  slowly
at  a  rate  of  1  mg/kg/min  for  a  total  dose  of  15  g/kg/min
3  min  before  induction  of  anesthesia.  Lidocaine  and
esmolol  infusions  were  terminated  immediately  after
extubation.
Heart  rates  (BPM);  systolic  (SBP),  diastolic  (DBP),  and
mean  (MABP)  arterial  blood  pressures;  and  the  SpO2 of
the  patients  were  measured,  and  adverse  effects  such  as
bradycardia,  hypotension,  and  arrhythmias  were  recorded
preoperatively  (t1),  after  induction  (t2),  after  the  intu-
bation  at  1  (t3)  and  5  (t4)  min  and,  during  the  surgical
incision  (t5),  after  the  surgical  incision  at  5  (t6),  10  (t7),  15
(t8),  20  (t9),  30  (t10),  40  (t11),  50  (t12),  and  60  (t13)  min,
before  extubation  (t14),  and  after  the  extubation  at  1  (t15)
and  5  (t16)  min.  During  induction,  2--2.5  mg/kg  iv  propo-
fol,  1  g/kg  iv  fentanyl,  and  0.1  mg/kg  iv  vecuronium  for
muscular  relaxation  were  used.  For  the  maintenance  of
anesthesia,  a  mixture  of  65%  N2O  and  35%  O2,  desﬂurane,
and  IV  vecuronium  at  a  dose  of  0.01  mg/kg  for  muscular
relaxation  were  administered  at  30  min  intervals.  Twenty
minutes  before  the  estimated  end  time  of  the  operation,
75  mg  IM  diclofenac  sodium  and  10  mg  IV  metochlopramide
were  administered.  Dosages  of  all  anesthetic  agents  were
tapered  50%  at  the  start  of  skin  suturing  and  discon-
tinued  at  the  last  skin  suture.  The  effects  of  muscular
relaxants  were  reversed  using  0.04  mg/kg  neostigmine  and
0.02  mg/kg  atropine.  The  time  interval  between  the  dis-
continuation  of  anesthetic  agents  and  the  spontaneous  eye
opening  of  the  patients  was  recorded  as  the  ‘‘awakening
time.’’
The  patients  were  brought  into  the  post-anesthesia  care
unit  (PACU)  after  extubation,  and  fentanyl  was  delivered
using  a  patient-controlled  analgesia  device  (PCAD).  The
PCAD  was  adjusted  to  deliver  an  initial  bolus  dose  of  3  cm3
(15  g)  fentanyl  (5  g/cm3)  with  a  lockout  time  of  20  min
and  a  1-h  limit  of  45  g.  A  loading  dose  was  not  admin-
istered.  SBP,  DBP,  MABP,  SS,  Ramsay  Sedation  Score,  and
resting  and  dynamic  VAS  scores  were  recorded  at  10  (t17),
20  (t18),  30  (t19),  and  40  (t20)  min  of  their  PACU  stay.  The
ﬁrst  demand  for  an  analgesic,  total  requirement  for  anes-
thesia,  modiﬁed  Aldrete  scores  at  10,  20,  30,  and  40  min,
and  the  time  to  achieve  a  MAS  of  ≥9  points  were  recorded.
The  patients  were  transferred  to  a  service  when  they  had
attained  a  modiﬁed  Aldrete  score  of  ≥9  points.  Heart  rates
(HRs);  systolic  (SBPs),  diastolic  (DBPs),  and  mean  arterial
(MABPs)  blood  pressures;  respiratory  rates;  Ramsay  seda-
tion  scores  (RSS);  maximal  resting  and  dynamic  VAS  scores;
number  of  demands  for  PCA;  amount  of  analgesics  admin-
istered;  and  adverse  effects,  including  nausea,  vomiting,
pruritus,  and  constipation,  among  others  were  recorded  at
2  (t21),  6  (t22),  12  (t23),  and  24  (t24)  h  of  hospital  stay
in  the  service.  Resting  VAS  scores  of  ≥4  points  at  any  time
during  the  postoperative  period,  despite  patient-controlled
analgesia,  necessitated  75  mg  diclofenac  sodium  IM  adminis-
tered  at  12  h  intervals,  which  was  recorded  as  an  additional
need  for  analgesia.  The  nausea  and  vomiting  scores  of  the
patients  were  as  follows:  0  =  absence  of  nausea,  1  =  mild
nausea,  2  = moderate  nausea  and  vomiting,  3  =  frequent
vomiting  and  4  =  severe  vomiting.  Metochlopramide  (10  mg
IV)  was  administered  when  the  nausea  and  vomiting  score
was  ≥2  points.tions  147
tatistical analysis
he  statistical  analysis  of  the  data  obtained  was  performed
sing  the  SPSS  for  Windows  16.0  statistical  package  pro-
ram.  The  data  were  expressed  as  arithmetic  means  ±  SD
standard  deviation),  numbers,  and  percentages.  Normal-
ty  tests  for  the  distribution  of  data  were  performed.  For
ntergroup  comparisons,  the  chi-square  and  Mann--Whitney
 tests  were  used.  The  Friedman  test  was  employed  in
ntragroup  comparisons.  For  parameters  showing  intergroup
ifferences,  the  Wilcoxon  t-test  with  Bonferroni  correction
as  used.  Values  with  p  < 0.05  were  accepted  as  statistically
igniﬁcant.
esults
ntergroup  difference  was  not  detected  for  demographic
haracteristics,  age,  gender,  body  weight,  or  height
p  >  0.05).
Heart  rates  (bpm)  measured  at  any  time  did  not  differ
etween  the  groups  (p  >  0.05).  Bradycardia  developed  in  the
idocaine  (n  =  1)  and  esmolol  (n  =  2)  groups  and  responded  to
he  administration  of  0.5  g  atropine.
In intergroup  comparisons,  systolic  blood  pressures
mmHg)  measured  following  the  induction  of  anesthesia
t2)  and  20  min  (t9)  after  surgical  incision  were  found  to
e  signiﬁcantly  lower  in  the  esmolol  group  (respectively,
 =  0.041;  p  =  0.045)  (Fig.  1).  In  the  lidocaine  group,  hyper-
ension  developed  in  two  patients,  and  was  treated  with  iv
00  g  nitroglycerine.
The  mean  arterial  blood  pressure  (mmHg)  in  the  esmolol
roup  measured  after  the  induction  of  anesthesia  (t2)  was
ower  relative  to  the  lidocaine  group  (p  =  0.006)  (Fig.  2).
In  all  of  the  measurement  periods,  intergroup  differences
ere  not  detected  for  diastolic  blood  pressure  and  periph-
ral  oxygen  saturation  (p  >  0.05).
No  intergroup  difference  was  encountered  regarding
ntraoperative  fentanyl  consumption  (group  L:
4.66  ±  45.08  g;  group  E:  82.50  ±  28.36  g)  (p  =  0.298).
dditional  fentanyl  was  required  in  both  the  lidocaine
n  =  10)  and  esmolol  (n  = 9)  groups.Time (min)
Group L Group E
Figure  1  Systolic  blood  pressures  (mmHg).  *p  <  0.05.
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Figure  2  Mean  blood  pressures  (mmHg).  *p  <  0.05.
Table  1  Ramsay  Sedation  Scores  (mean  ±  SD).
Time  Group  L  Group  E  p
t17  2.76  ±  0.62 2.33  ±  0.80 0.015
t18  2.26  ±  0.52 2.03  ±  0.55  0.105
t19 2.00  ±  0.00 1.93  ±  0.25 0.154
t20  2.00  ±  0.00 2.00  ±  0.00  1.000
t21 2.00  ±  0.00 2.00  ±  0.00 1.000
t22  2.00  ±  0.00 2.00  ±  0.00 1.000
t23  2.00  ±  0.00 2.00  ±  0.00 1.000
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ct24  2.00  ±  0.00  2.00  ±  0.00  1.000
hile  hypertension  occurred  in  both  the  lidocaine  (n  =  1)  and
smolol  (n  =  2)  groups.
Postoperative  diastolic,  mean  arterial  blood  pressures
nd  heart  rates  were  not  different  between  the  groups  in
ll  measurement  periods  (p  >  0.05).
The  recovery  times  (min)  of  the  cases  were  signiﬁcantly
horter  in  the  esmolol  group  (group  L:  6.55  ±  1.84  and  group
:  4.56  ±  1.40)  (p  =  0.0001).
In intergroup  comparisons,  the  Ramsay  Sedation  Scores
stimated  10  min  after  extubation  (t17)  were  lower  in  the
smolol  group  (p  =  0.015)  (Table  1).
The  modiﬁed  Aldrete  scores  during  the  recovery  period
ere  signiﬁcantly  lower  in  the  lidocaine  group  (p  <  0.05)
Table  2).
The  modiﬁed  Aldrete  scores  of  ≥9  points  were  attained  in
 signiﬁcantly  shorter  time  (min)  in  the  esmolol  group  (group
:  14.76  ±  3.82  and  group  E:  12.46  ±  4.80)  (p  =  0.006).
Postoperative  VAS  values  calculated  at  rest  and  10  (t17)
nd  20  (t18)  min  after  extubation  were  found  to  be  signiﬁ-
antly  higher  in  the  lidocaine  group  (p  =  0.017  and  p  =  0.006,
espectively).
Table  2  Modiﬁed  Aldrete  scores  (mean  ±  SD).
Time  Group  L  Group  E  p
t17  8.23  ±  0.43  8.53  ±  0.51  0.018
t18 9.00  ±  0.00  9.27  ±  0.52  0.006
t19 9.30  ±  0.46  9.70  ±  0.46  0.002
t20 9.7  ±  0.46  9.93  ±  0.25  0.002
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Postoperative  dynamic  VAS  values  detected  10  (t17)  and
0  (t18)  min  after  extubation  were  signiﬁcantly  higher  in  the
idocaine  group  relative  to  the  esmolol  group  (p  =  0.021  and
 = 0.003,  respectively).
The  number  of  demands  for  postoperative  PCA,  the
mount  of  analgesics  administered,  and  the  time  to  the
rst  requirement  of  analgesia  estimated  in  all  measurement
eriods  were  not  statistically  signiﬁcantly  different  between
he  groups  (p  >  0.05).
Fewer  patients  in  the  lidocaine  group  required  addi-
ional  analgesics  [group  L:  2  (6.7%)  and  group  E:  11  (36.7%)]
p  =  0.005).
Any  statistically  signiﬁcant  intergroup  difference  was  not
etected  regarding  intra-  and  postoperative  side  effects
p  >  0.05).  During  the  operation,  one  patient  in  the  lido-
aine  group  and  two  patients  in  the  esmolol  group  developed
radycardia  responsive  to  0.5  mg  atropine.  In  the  lido-
aine  group,  two  patients  developed  hypertension,  which
esponded  to  100  g  nitroglycerine.  During  the  postopera-
ive  period,  hypotension  developed  in  one  patient  in  the
idocaine  (n  =  1)  group,  while  hypertension  was  noted  in  the
idocaine  (n  =  1)  and  esmolol  (n  =  2)  groups.  Nausea  and  vomi-
ing  were  seen  in  four  patients  in  each  group  and  treated
ith  10  mg  metochlopramide.
iscussion
hough  laparoscopic  cholecystectomy  offers  the  possibility
f  relatively  early  discharge  from  the  hospital,  postopera-
ive  pain,  nausea,  and  vomiting  induced  by  opioids  are
requent  complaints.13,14 Multimodal  analgesic  techniques
nd  adjuvant  agents  employed  to  decrease  the  incidence
f  these  side  effects  might  be  useful  in  reducing  dosages  of
ystemic  opioids.13,14
Chia  et  al.15 administered  esmolol  infusions  at  a  rate  of
0  g/kg/min  following  a loading  dose  of  0.5  mg/kg  before
he  induction  of  anesthesia  in  49  patients  who  had  under-
one  abdominal  hysterectomy,  while  48  patients  received
ormal  saline  infusions.  They  also  demonstrated  that  the
esponse  of  the  heart  rate  and  blood  pressure  to  surgi-
al  incision  and  extubation  was  signiﬁcantly  suppressed  in
he  esmolol  group.  White  et  al.16 administered  esmolol
nfusions  at  a  rate  of  5  g/kg/min  following  a  loading  dose
f  50  mg  before  the  induction  of  anesthesia  in  15  patients
ndergoing  gynecologic  laparoscopic  surgeries,  while  15
atients  received  only  50  mg  esmolol  IV  and  then  esmolol
nfusions  (5  g/kg/min)  following  the  administration  of  1  mg
icardipine.  Still,  15  patients  received  saline  infusions.  They
oncluded  that  esmolol  infusions  per  se  or  in  combination
ith  nicardipine  were  sufﬁciently  effective  in  suppressing
ntraoperative  acute  hemodynamic  responses.  Keskin  et  al.17
ompared  esmolol  and  lidocaine  in  the  prevention  of  hemo-
ynamic  responses  developed  secondary  to  laryngoscopy,
ntubation,  and  extubation.  To  that  end,  they  initially  deliv-
red  IV  esmolol  infusions  at  a  rate  of  0.5  mg/kg  for  1  min
o  50  patients  scheduled  for  laparotomy;  then,  the  dose
f  IV  infusion  was  increased  to  200  g/kg,  delivered  for min.  However,  50  patients  received  only  lidocaine  IV  at  a
ose  of  1.5  mg/kg  for  1  min,  whereas  50  patients  were  given
qual  volumes  of  physiological  saline  infusions.  They  stated
hat  esmolol  and  lidocaine  had  equipotently  depressed
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eLidocaine  versus  esmolol  in  laparoscopic  cholecystectomy  o
hemodynamic  responses  that  developed  during  intubation
but  failed  to  adequately  suppress  hemodynamic  responses
that  evolved  during  extubation.
We  think  that  differences  among  these  outcomes  are
related  to  the  application  of  premedication  (if  any),  drugs
used  in  induction,  and  doses  of  the  study  drugs.  In  addition,
in  our  study,  lidocaine  and  esmolol  equally  depressed  hemo-
dynamic  responses  to  intubation.  Even  though  hemodynamic
responses  to  extubation  were  suppressed  more  effectively  in
the  lidocaine  group  relative  to  the  esmolol  group,  doses  of
both  agents  we  used  could  not  completely  attenuate  hemo-
dynamic  responses  to  extubation.  Chia  et  al.15 delivered
esmolol  infusions  at  a  rate  of  50  g/kg/min  following  a  load-
ing  dose  of  0.5  mg/kg  in  patients  scheduled  for  abdominal
hysterectomy  and  found  signiﬁcantly  lower  intraoperative
opiate  and  volatile  agent  consumption  compared  with  the
control  group.  Topc¸u  et  al.18 stated  that  the  total  consump-
tion  of  remifentanil  and  propofol  was  signiﬁcantly  lower
in  the  group  of  patients  scheduled  for  elective  abdomi-
nal  surgery  under  total  intravenous  anesthesia  who  also
received  osmolol  infusion  at  a  rate  of  250  g/kg/min  com-
pared  with  the  control  group.  Lauwick  et  al.7 investigated
the  effects  of  intraoperative  lidocaine  infusion  in  patients
scheduled  for  laparoscopic  cholecystectomy  and  indicated
lesser  consumption  of  intraoperative  fentanyl  and  desﬂu-
rane  in  the  group  that  received  lidocaine  infusion  at  a  rate  of
2  mg/kg/h  following  a  loading  dose  of  1.5  mg/kg  compared
with  the  control  group.  They  also  stated  that  esmolol  and
lidocaine  infusions  led  to  lesser  intraoperative  opiate  and
volatile  agent  consumption  relative  to  the  control  group.
However,  no  study  has  compared  both  of  these  agents  in
this  respect.  In  our  study,  we  could  not  detect  any  signiﬁ-
cant  difference  between  the  total  amounts  of  intraoperative
fentanyl  consumed  by  the  groups.
Koppert  et  al.19 investigated  the  effects  of  perioperative
lidocaine  infusion  in  major  abdominal  surgeries  and  initi-
ated  lidocaine  infusion  at  a  rate  of  1.5  mg/kg/h  following  a
loading  dose  of  1.5  mg/kg  lidocaine  IV  30  min  before  surgical
incision  in  20  patients  undergoing  major  abdominal  surger-
ies.  Infusion  was  discontinued  1  h  after  the  termination  of
surgery.  The  authors  also  stated  that,  when  they  had  infused
the  same  volume  of  physiologic  saline  to  the  control  group,
they  could  not  ﬁnd  any  intergroup  difference  in  sedation
scores.  Collard  et  al.11 analyzed  the  effects  of  intraoperative
esmolol  infusion  on  the  postoperative  consumption  of  fen-
tanyl  in  laparoscopic  cholecystectomies.  The  investigators
delivered  esmolol  to  30  patients  at  a  rate  of  5--15  g/kg  fol-
lowing  a  loading  dose  of  1  mg/kg,  while  another  30  patients
received  esmolol  infusions  at  a  rate  of  0.1--0.5  g/kg/min
after  a  loading  dose  of  1  g/kg.  Furthermore,  30  patients
were  given  physiological  saline  solutions,  and  shorter  recov-
ery  times  were  detected  in  the  esmolol  group  compared
with  the  other  groups.  Many  studies  have  demonstrated  that
beta  adrenergic  blockers  that  exert  depressive  effects  on
the  central  nervous  system  also  decrease  the  need  for  intra-
operative  anesthetic  agents,  leading  to  rapid  recovery  from
anesthesia.11,16,20 In  the  literature,  we  encountered  no  study
comparing  esmolol  and  lidocaine  regarding  awakening  times
and  recovery  scores.  In  our  study,  awakening  times  were
shorter  in  the  esmolol  group.  Ramsay  Sedation  Scores  esti-
mated  10  min  after  extubation  were  found  to  be  higher  in
the  lidocaine  group  relative  to  the  esmolol  group.  However,
c
n
qtions  149
o  signiﬁcant  intergroup  difference  was  found  at  other  mea-
urement  time  points.  Modiﬁed  Aldrete  recovery  scores  in
he  esmolol  group  were  signiﬁcantly  higher  in  all  measure-
ent  periods.  Similarly,  the  time  to  achieve  a score  of  ≥9
oints  was  also  shorter  in  the  esmolol  group.
Chia  et  al. 15 investigated  the  effects  of  beta  blockers  on
ostoperative  pain  in  patients  who  had  undergone  abdomi-
al  hysterectomies  and  found  that  the  VAS  scores  of  patients
ho  received  IV  esmolol  infusion  at  a  rate  of  50  g/kg/min
ollowing  a  loading  dose  of  0.5  mg/kg  before  the  induction
f  anesthesia  were  similar  to  those  of  the  control  group
ith  signiﬁcantly  lower  requirements  for  postoperative  mor-
hine  supplementations  in  the  esmolol  group.  Öztürk  et  al.21
dministered  esmolol  infusions  at  a  rate  of  5--15  g/kg/min
ollowing  a  loading  dose  of  1  mg/kg,  while  their  control
roup  received  equal  volumes  of  ringer  lactate  infusions.
n  the  esmolol  group,  the  postoperative  need  for  analgesics
as  signiﬁcantly  lower  relative  to  the  control  group.  Collard
t  al.11 investigated  the  effects  of  intraoperative  esmolol
nfusions  on  postoperative  fentanyl  consumption  in  patients
ndergoing  laparoscopic  cholecystectomy  and  administered
smolol  infusions  to  30  patients  at  a  rate  of  5--15  g/kg/min
ollowing  a  loading  dose  of  1  mg/kg.  Whereas  30  patients
eceived  remifentanil  infusion  (0.1--0.5  g/kg/min)  after  a
oading  dose  of  1  g/kg,  another  30  patients  were  given  only
hysiological  saline  infusions.  The  authors  demonstrated
hat  the  group  that  received  esmolol  infusion  during  the
ostoperative  period  required  lesser  amounts  of  fentanyl.
oppert  et  al.19 analyzed  the  effects  of  perioperative  lido-
aine  infusion  in  major  abdominal  surgeries  and  found  that,
n  patients  who  had  received  lidocaine  infusion  at  a  rate  of
.5  mg/kg/h  following  a  loading  dose  of  1.5  mg/kg  30  min
efore  surgical  incision  up  to  the  end  of  surgery  demanded
ewer  numbers  of  PCA  and  less  morphine  administered  via
CA,  and  the  total  consumption  of  morphine  was  relatively
ower  compared  with  the  control  group.  In  our  study,  we
ound  no  difference  between  groups  in  the  time  to  the
rst  requirement  for  an  analgesic,  the  number  of  demands
or  PCA,  and  the  amount  of  fentanyl  delivered  by  PCA.  In
oth  groups,  even  though  the  total  amount  of  postoperative
pioid  consumption  was  nearly  equal,  we  detected  lower
equirements  for  additional  analgesics  in  patients  who  had
eceived  lidocaine  infusion.  Early  postoperative  resting  and
ynamic  VAS  scores  in  the  esmolol  group  were  comparatively
ower,  but  in  the  long  term,  the  VAS  scores  determined  in  all
easurement  periods  did  not  differ  between  the  esmolol
nd  lidocaine  groups.  It  has  been  recognized  that  the  intra-
enous  administration  of  sodium  channel  blockers  such  as
idocaine  has  antinociceptive  effects  via  its  impact  on  dorsal
pinal  horn  neurons.22 However,  some  studies  have  revealed
hat  esmolol  decreased  the  requirement  for  anesthetic
gents  and  ensured  rapid  recovery  from  anesthesia  through
ts  depressive  effects  on  the  central  nervous  system.11,16,20
ympathomietic  drugs  acting  on  the  central  nervous  sys-
em  are  known  to  alter  the  need  for  anesthetic  agents.
he  detection  of  lower  VAS  scores  at  10  and  20  min  after
xtubation  can  be  explained  by  the  antagonistic  effects  of
smolol  on  catecholamine  synthesis  in  the  brain  and  spinal
ord.
In  laparoscopic  surgeries,  the  incidence  of  postoperative
ausea/vomiting  is  40--75%,  and  it  is  especially  more  fre-
uently  seen  on  the  ﬁrst  and  second  postoperative  days.23
1N
a
w
s
t
t
t
l
u
a
c
n
s
t
e
C
W
i
i
t
s
a
s
p
t
a
g
s
a
o
w
s
s
C
T
R
1
1
1
1
1
1
1
1
1
1
2
2
250  
ausea  and  vomiting,  residual  effects  of  anesthetic  drugs
nd  opioids,  and  gastric  distension  might  become  apparent
ith  ambulation  and  hypotension.23 Opioids  can  induce  nau-
ea  and  vomiting  not  only  by  stimulating  the  chemoreceptor
rigger  zone  in  the  brain  stem  but  by  delaying  gastric  emp-
ying  and  their  hypotensive  effects.23 In  comparison  with
he  remifantil  group,  Coloma  et  al.12 detected  signiﬁcantly
ower  incidence  of  nausea  and  vomiting  in  the  esmolol  group
ndergoing  laparoscopic  gynecologic  surgeries.  Similarly,  in
 study  investigating  the  effects  of  lidocaine  in  laparoscopic
holecystectomies,  Lauwick  et  al.7 observed  lower  rates  of
ausea  and  vomiting  relative  to  the  control  group.  In  our
tudy,  we  also  noted  treatment-requiring  nausea  and  vomi-
ing  with  similar  degrees  of  severity  in  the  lidocaine  and
smolol  groups.
onclusion
e  found  that  intraoperative  lidocaine  and  esmolol  infusions
n  laparoscopic  cholecystectomies  exert  comparatively  sim-
lar  suppressive  effects  on  hemodynamic  responses  to
racheal  intubation  and  surgical  incision,  and  they  are  not
uperior  to  each  other  regarding  the  need  for  intraoperative
nd  postoperative  opioid  analgesics  and  the  development  of
ide  effects.  We  also  noted  that  lidocaine  infusion  was  com-
aratively  superior  in  the  suppression  of  the  response  to
racheal  extubation  and  postoperative  need  for  additional
nalgesia;  however,  esmolol  infusion  was  more  advanta-
eous  regarding  awakening  time,  early  postoperative  pain
core,  modiﬁed  Aldrete  recovery  (MAS)  score,  and  time  to
chieve  a  MAS  of  9  points.  In  the  comparison  of  the  efﬁcacy
f  these  two  adjuvant  agents,  in  various  types  of  surgery,
e  think  that  further  controlled  studies  to  evaluate  the  con-
umption  of  anesthetic  agents  using  different  drug  dosages
hould  be  conducted.
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